Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01060787 · ClinicalTrials.gov registry record
Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant
A clinical trial, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- 98
- Enrollment target
NCT01060787 is a clinical trial that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 98 participants.
The verdict
NCT01060787 has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants
Interventions
- PROCEDURE Fluocinolone Acetonide 0.59 mg
- PROCEDURE Fluocinolone Acetonide 2.1 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2016-02-04 |
| Est. Completion | 2019-06-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01060787
The ClinicalTrials.gov registry entry for NCT01060787 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fluocinolone Acetonide 0.59 mg is the first listed.
NCT01060787 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01060787 about?
NCT01060787 is a clinical study titled "Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant". Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants
What is the current status of trial NCT01060787?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2016-02-04. Estimated completion is 2019-06-07.
What interventions are being tested in trial NCT01060787?
The interventions under investigation include: Fluocinolone Acetonide 0.59 mg (PROCEDURE), Fluocinolone Acetonide 2.1 mg (PROCEDURE).
Who is sponsoring clinical trial NCT01060787?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.